All Disease X articles
-
NewsKorea University Vaccine Innovation Center teams with Moderna on mRNA-based hantavirus vaccine development
The Vaccine Innovation Center at Korea University College of Medicine has entered into a full-scale collaboration with global pharmaceutical company Moderna to develop an mRNA-based hantavirus vaccine.
-
NewsDisease X is a threat to free societies - so pandemic preparedness is vital this time round
The Covid-19 pandemic uncovered fracture lines in society that have the potential to destabilize free societies by internal and external groups using misinformation on social media, a new review warns.
-
NewsCEPI and WHO urge broader research strategy for countries to prepare for the next pandemic
The Coalition for Epidemic Preparedness Innovations (CEPI) and the World Health Organization (WHO) today called on researchers and governments to strengthen and accelerate global research to prepare for the next pandemic.
-
NewsVaccine approach offers promise to induce longer-lasting protective immunity against COVID-19
A scientific team has engineered a COVID-19 vaccine that induced – in pre-clinical models – very long-lasting, protective immunity against SARS-CoV-2 virus with a single-shot immunisation.
-
NewsMore than half of global infectious diseases experts surveyed rate influenza as the number one pathogen of concern of pandemic potential
When infectious diseases experts were asked to rank pathogens in order of their pandemic potential, influenza was considered the pathogen of highest pandemic risk, with 57% ranking it as number one, and 17% ranking it second.
-
NewsVirus ancestry could aid bid to predict next pandemic, study finds
Virus family history could help scientists identify which strains have potential to become the so-called Disease X that causes the next global pandemic.
-
NewsPartnership to use AI to speed up vaccine development against Disease X
CEPI, the Coalition for Epidemic Preparedness Innovations, and the Houston Methodist Research Institute (HMRI), have announced a partnership to combine cutting-edge artificial intelligence (AI) technology with established laboratory techniques to speed up development of future vaccines against novel viral threats.
